Trial Profile
A retrospective trial to study safety & pharmacokinetics of lacosamide for the treatment of patients in the ICU for refractory status epilepticus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 May 2021
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Seizures; Status epilepticus
- Focus Adverse reactions; Pharmacokinetics
- 23 Mar 2016 New trial record